Beijing New drug industry after years of loss but throw billion buy "mansion"

In the property market to regulate the housing price bearish environment, main years of losses in Beijing New drug industry (002020, closing price of 13.70 yuan) but dare to throw billions of dollars against the trend to buy "mansion"! From the financial situation of the new drug industry, the purchase of such commercial real estate is undoubtedly a too extravagant investment, in the end what is the reason for Beijing's new drug industry so hurriedly investment to buy a house?　　Will the purchase of the new drug industry in Beijing how much impact? Since the listing in 2004, Beijing New drug industry performance bleak, from 2008 the main business more into the situation of successive losses, but it is such a continuous decline in business enterprises, but is prepared to spend 118 million yuan to buy top office buildings in Hangzhou, and the office unit price unexpectedly more than 38,000 yuan/square meters,　　In the housing market to control the bearish environment, its contrarian purchase of "luxury" behavior of many investors puzzled. Beijing's new drug industry last year's net assets of only 303 million yuan, 118 million yuan in the purchase of the equivalent of 39% of its net assets, and more than 80 million yuan can only be solved through bank loans.　　The daily economic news reporter after careful relevant information also found that the loan to buy a building will greatly increase the financial burden of listed companies, the future performance pressure is greater.　　Access to historical data, since 2005, the Beijing New drug industry has not sent investors a share of red shares, divided into a cash dividend for 5 consecutive years.　　Total purchase price of the company's net assets 40% according to 365 Real Estate Home Network Introduction, Hangzhou UCD times MANSION Business OFFICE is located in Hangzhou Qianjiang New Town CBD Center, overlooking the Qiantang River landscape, is Qianjiang New Town CBD "center."　　Beijing New Drug purchase is the UCD building of the 24 and 25 floors, of which the 24-storey unit price of 38220 yuan per square meter, 25 per square meter 38510 yuan, the total price reached 118 million yuan. Judging from the financial situation of Beijing's new drug industry, buying such a commercial property is an overly extravagant investment, and the company's existing funds cannot afford to pay such high prices. At the end of last year, the net worth of new drug industry was only 303 million yuan, 118 million yuan was equivalent to 39% of its net assets. In the announcement, the Beijing new drug industry also said that, because the current company book own funds only more than 60 million yuan, so the purchase of the company will take the mortgage, down payment 50%, 5-year mortgage. And the first payment of 59.04 million yuan, the company's own funds to pay a portion of only 30 million yuan, and another 30 million yuan to be resolved through bank loans. The mortgage payment is expected to commence in August, with a monthly payment of about $1.2 million.　　In other words, the company's money to buy the house, more than 80 million yuan can only be solved through the bank loans.　　Buy a building more than tens of millions of dollars a year so the purchase of the building in the end can bring to the company what effect? In the announcement, Beijing new drug industry admits: "This transaction will make a certain financial pressure on the company, the annual increase in financial costs is estimated to be about 6.3 million yuan, increase depreciation of about 3.4 million yuan, the total impact of profit of about 9.7 million yuan." "In fact, since 2006, the results of the new drug industry has shown a declining trend. In 2006, the company belonged to the shareholders of the listed company's net profit of 14.03 million Yuan, 2007 only 1.5 million Yuan, 2008 is a huge loss of 17.73 million yuan. 2009-year results, although the achievement of 3.75 million yuan, but the government subsidies accounted for 4.25 million yuan, the deduction of non-recurrent profits after the profit is-1.47 million yuan. Although the company said the interim results will be a major improvement this year, but also expected only 4 million ~600 million.　　If the annual increase of 9.7 million yuan in interest payments and depreciation costs, Beijing new drug industry will bear more pressure on performance.　　Yesterday afternoon, "Daily economic news" reporter called Beijing New Drug Industry board Secretary Office, but the company's securities representative in response to reporters, all the "we have made it clear in the bulletin" as a response.　　Or there are some suspected infringement of the interests of small and medium-sized shareholders in the industry in the press consultation, the Beijing New drug industry behavior expressed a great understanding. Minsheng Securities an analyst told the Daily Economic news reporter, Beijing's new drug industry will be the net worth of nearly 40% to buy property, the motivation is certainly not just for headquarters office so simple.　　Taking into account the Beijing new drug industry chairman and the actual control of the people are a person, do not rule out the use of this project to infringe on the interests of small and medium-sized shareholders. In addition, the reporter also found that Beijing new drug industry This House has first car after the suspect: the company on May 4 has been with UCD developers HANGZHOU HUALIAN REAL Estate Co., Ltd. signed a subscription book and paid a deposit of 10 million yuan, but the board resolution was made on May 12.　　The shareholders ' meeting will not be held until June 1. What prompted Beijing's new drug industry to invest so hastily in buying a house? Will the purchase of the new drug industry in Beijing how much impact? "Daily economic news" will be further tracked.